Tag: GE healthcare

May 8, 2018

Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress

Cellular Biomedicine (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative...
April 4, 2018

6 ASX Medical Device Stocks

These companies are engaged in a wide range of compelling research around everything from respiratory devices and inflatable tissue to...
March 15, 2018

Top 10 Stem Cell Companies On The NASDAQ

The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
March 8, 2018

4 Gene Editing Technologies Explained

We look at four types of gene editing currently in clinical trials, as well as the pros and cons of...
March 6, 2018

Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress

Cellular Biomedicine Group (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies...
January 19, 2018

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

Cellular Biomedicine Group (NASDAQ:CBMG), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer, has announced its...
June 26, 2017

Q Biomed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today that Christopher Manuele will join the Strontium 89 Chloride commercialization...